Global medtech frontrunner Getinge is intensifying its focus on the Indian market by leveraging its India Innovation Centre (IIC) and forging strong alliances with industry and academia to cater to a worldwide audience. The company maintains a robust market presence in India across various product categories, including ventilators (30%), heart-lung machines (50%), intra-aortic balloon pumps (70%), extracorporeal membrane oxygenation (ECMO) (90%), and operating room tables (25%).
Aruna Nayak, Managing Director of Getinge India Pvt. Ltd., underscored the company’s substantial contributions to India’s healthcare advancements, especially during the COVID-19 pandemic. Getinge equipped healthcare professionals with essential tools by supplying record numbers of advanced ventilators and ECMO products. Their service engineers also tackled roughly 10,000 service calls related to these devices.
Nayak further noted that India has become one of Getinge’s top 10 global markets, and the company is presently collaborating with 10,000 Indian hospitals to establish a world-class infrastructure. Getinge is dedicated to introducing, manufacturing, and distributing high-end technologies and devices in India, making them accessible in the US and the European Union. The company is well-equipped to serve the Indian market with premium products as healthcare infrastructure investments continue to expand.
In pursuit of their Indian growth strategy, Getinge inaugurated an Innovation Centre in Bangalore in January 2020. This facility is devoted to developing cutting-edge and cost-efficient solutions for emergency critical care and clinical trials. Moreover, Getinge has joined forces with IIT Bombay’s School of Biomedical Engineering to create inventive and affordable emergency critical care solutions, informed by pandemic experiences.